Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Next-Generation Antibody-Drug Conjugate for Treating Lung Cancer with George Eliades Mythic Therapeutics TRANSCRIPT
Download PDFDec 14, 2024
George Eliades, the CEO of Mythic Therapeutics a company focused on the next generation of antibody-drug conjugates, ADCs, to treat cancer. Their approach aims to expand the population of patients who can benefit from ADCs by targeting proteins expressed at low levels on cancer cells. The company's lead candidate...
Dec 14, 2024
George Eliades, the CEO of Mythic Therapeutics a company focused on the next generation of antibody-drug conjugates, ADCs, to treat cancer. Their approach aims to expand the population of patients who can benefit from ADCs by targeting proteins expressed at low levels on cancer cells. The company's lead candidate...
Tech-Enabled Support for Older Adults and Caregivers to Navigate Government Programs and Services with Karl Ulfers DUOS TRANSCRIPT
Download PDFDec 12, 2024
Karl Ulfers, CEO and Co-Founder of DUOS, helps older adults and their caregivers access government benefits and programs to improve the quality of life and enable aging in place. Working with Medicare Advantage and dual-eligible health plans, DUOS uses a combination of technology, generative AI, and personalized...
Dec 12, 2024
Karl Ulfers, CEO and Co-Founder of DUOS, helps older adults and their caregivers access government benefits and programs to improve the quality of life and enable aging in place. Working with Medicare Advantage and dual-eligible health plans, DUOS uses a combination of technology, generative AI, and personalized...
Enabling Clinicians to Use AI for Hyper-Personalized Care with Dr. Ed Glynn RhythmX AI TRANSCRIPT
Download PDFDec 12, 2024
Dr. Ed Glynn, Chief Clinical Officer at RhythmX AI, is bridging the gap between real-world clinical data and the use of artificial intelligence. One of the key problems RhythmX is trying to solve is the cognitive burden on primary care clinicians to understand all relevant details about each patient. Using the RhythmX...